Osbourn J K, Field A, Wilton J, Derbyshire E, Earnshaw J C, Jones P T, Allen D, McCafferty J
Cambridge Antibody Technology Limited, Melbourn, Cambridgeshire, UK.
Immunotechnology. 1996 Sep;2(3):181-96. doi: 10.1016/s1380-2933(96)00046-2.
A human single chain Fv (scFv) specific for human carcinoembryonic antigen (CEA) has been isolated from a 2.0 x 10(9) phage display library from unimmunised human donors. The dissociation constant of the scFv has been measured by surface plasmon resonance (SPR) and found to be 7.7 x 10(-9) M, with an off-rate component of 6.2 x 10(-3) s-1. In order to investigate directly whether increased affinity leads to improved targeting of CEA-positive tumours, this scFv has been affinity matured by both targeted mutagenesis of the CDRs of heavy and light chains, and by light chain shuffling.
A partial randomisation scheme, biased towards amino acids commonly found as somatic mutations of germline antibody sequences, was used for directed diversification of VH and VL CDR3s. Diversification of the entire VL region was also introduced by light chain shuffling of the parental anti-CEA scFv. Selection of the mutagenised repertoires was carried out to enrich for antibodies with a reduced koff.
Sequencing the selected clones identified a number of amino acid changes in the VH CDR3, one of which gave a four-fold reduction in koff. Stringent selection of the light chain shuffled library resulted in several clones with a two- to three-fold reduction in koff. It has been possible to combine the selected changes from both mutagenesis approaches by using the mutagenised heavy chain and a light chain derived by shuffling to give a human scFv with a dissociation constant for human CEA of 6.0 x 10(-10) M.
A panel of human anti-CEA scFvs has been generated with differing dissociation constants for antigen, which will allow the correlation between tumour targeting efficiency in relation to binding affinity to be assessed directly. The scFv panel will be valuable in the optimisation of human antibodies for immunotherapy.
从未免疫的人类供体的2.0×10⁹噬菌体展示文库中分离出一种针对人类癌胚抗原(CEA)的人单链Fv(scFv)。通过表面等离子体共振(SPR)测量了该scFv的解离常数,发现为7.7×10⁻⁹ M,解离速率常数为6.2×10⁻³ s⁻¹。为了直接研究亲和力的提高是否会导致对CEA阳性肿瘤的靶向性改善,通过对重链和轻链的互补决定区(CDR)进行靶向诱变以及轻链改组,对该scFv进行了亲和力成熟。
采用一种偏向于种系抗体序列体细胞突变中常见氨基酸的部分随机化方案,对VH和VL CDR3进行定向多样化。通过亲本抗CEA scFv的轻链改组,也引入了整个VL区域的多样化。对诱变文库进行筛选,以富集解离速率常数降低的抗体。
对所选克隆进行测序,在VH CDR3中鉴定出多个氨基酸变化,其中一个使解离速率常数降低了四倍。对轻链改组文库进行严格筛选,得到了几个解离速率常数降低了两到三倍的克隆。通过使用诱变的重链和改组衍生的轻链,有可能将两种诱变方法中所选的变化结合起来,得到一种对人CEA的解离常数为6.0×10⁻¹⁰ M的人scFv。
已产生了一组针对抗原具有不同解离常数的人抗CEA scFv,这将使人们能够直接评估肿瘤靶向效率与结合亲和力之间的相关性。该scFv组在优化用于免疫治疗的人抗体方面将具有重要价值。